BridgeMD
New treatment option for Calcaneus Fracture
Official title Primary Subtalar Arthrodesis for Calcaneal Fractures
ClinicalTrials.gov ID: NCT06249126
What this study is testing
- What it's testing
- Management of severe injuries to the heel (displaced intra-articular calcaneus fractures) continues to be a major challenge for orthopedic surgeons. Previous studies have demonstrated poor outcomes, and results show that patients experience long-term pain and decreased quality of life postoperatively.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Undergoing operative treatment for displaced intra-articular calcaneus fracture
- Sanders III and IV displaced intra-articular calcaneus fracture OR Sanders II with any of the following criteria: Bohler angle \< 0 degrees, open...
- Age 18 or older
- Able to follow up at site for 1 year
You likely can't join if
- Planned surgery using extensile lateral approach
- Sanders II displaced intra-articular calcaneus fracture without: Bohler angle \< 0 degrees, open fracture, pain syndrome, or substance
- \<18 years of age
- Body Mass Index (BMI) \>40
- Unable to follow up at site for 1 year
- Patients that speak neither English or Spanish
See the full eligibility criteria
- Undergoing operative treatment for displaced intra-articular calcaneus fracture
- Sanders III and IV displaced intra-articular calcaneus fracture OR Sanders II with any of the following criteria: Bohler angle \< 0 degrees, open fracture, pain syndrome, substance use disorder
- Age 18 or older
- Able to follow up at site for 1 year
- Planned surgery using extensile lateral approach
- Sanders II displaced intra-articular calcaneus fracture without: Bohler angle \< 0 degrees, open fracture, pain syndrome, or substance
- \<18 years of age
- Body Mass Index (BMI) \>40
- Unable to follow up at site for 1 year
- Patients that speak neither English or Spanish
- Prisoner
The study team makes the final eligibility decision.
Where it's taking place
- Orange, California, United States
- Atlanta, Georgia, United States
- Macon, Georgia, United States
- Chicago, Illinois, United States
- Lexington, Kentucky, United States
- New Orleans, Louisiana, United States
- Baltimore, Maryland, United States
- Jamaica, New York, United States
- New York, New York, United States
- Chapel Hill, North Carolina, United States
- Charlotte, North Carolina, United States
- Concord, North Carolina, United States
- Winston-Salem, North Carolina, United States
- Greenville, South Carolina, United States
- Nashville, Tennessee, United States
- Galveston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Orange, California, United States; Atlanta, Georgia, United States; Macon, Georgia, United States; Chicago, Illinois, United States; Lexington, Kentucky, United States; New Orleans, Louisiana, United States and 10 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.